相关实验视频
Updated: Jul 7, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.0K
通过皮肤取消HeartWare左心室辅助装置 (HVAD) 支持后的长期结果:10年更新
Chokanan Thaitirarot1,2, Leonard M Shapiro3, Clive Lewis1
1Transplant Unit, Royal Papworth Hospital, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
JHLT open
|March 27, 2025
概括
植入式左心室辅助器件 (LVADs) 的皮肤式退役可以导致长期恢复. 一名17岁的男性在去除LVAD后,经历了10年的心力衰竭症状自由.
科学领域:
- 心脏病学 心脏病学
- 机械循环支持 机械循环支持
背景情况:
- 植入式左心室辅助器件 (LVAD) 用于高级心力衰竭.
- 穿皮式设备退役提供了一个潜在的替代品,而不是 explantation.
- 通过皮肤取消LVAD后的长期结果尚未得到充分证实.
研究的目的:
- 报告了一名经过皮肤穿透式LVAD退役的患者的10年随访情况.
- 评估在机械循环支器被取消后将多余的LVAD留在现场的长期安全性和有效性.
主要方法:
- 使用Amplatzer血管插头,通过皮肤关闭可植入的LVAD.
- 长期的临床和心声回声监测.
- 监测天然尿素水平和不良事件.
主要成果:
- 患者在LVAD停用10年后仍然没有心力衰竭症状.
- 轻微受损的左心室尺寸和缩功能持续存在,但在血液动力学上是稳定的.
- 没有观察到与退役的LVAD,驱动线残留物或抗凝剂相关的不良事件.
结论:
- 通过皮肤的LVAD退役可以促进长期生存,没有不良事件.
- 这种方法可能是一个可行的选择,患者桥梁恢复.
- 在机械支撤出后将多余的LVAD留在现场是可行的和安全的.
相关概念视频
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

